AskTheDate.com
Back to calendar

Xilio Therapeutics, Inc. (XLO) Earnings

XLO reports earnings on Wednesday, August 12, 2026

earnings report
August 12, 2026
Q2 2026
Est. EPS: $-0.92
Actual EPS: $-0.59
EPS surprise: 0.00%
Company overview
Market Cap$59.5M
PriceUSD 9.05
EPS (TTM)-1.69
52-week high12.74
52-week low6.47
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees76